Tabuk Pharmaceuticals signs a Commercial Agreement with Renapharma AB

Tabuk Pharmaceuticals Manufacturing Company (“Tabuk”), one of the leading pharmaceutical companies in the Middle East and North Africa region, has entered into an exclusive agreement with Renapharma AB (“Renapharma”) on Cholecalciferol Vitamin D3 drops (“Detremin”), Renapharma is a leading Swedish company that creates and develops innovative and highly competitive pharmaceutical, nutraceutical and med-tech products. (Logo: […]